Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tramadol for Prevention of Postpartum Depression
NCT03309163Phase 4Completed
- Sponsor
- Xinqiao Hospital
- Start
- Oct 2017
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of tramadol in postpartum depression (PPD), sponsored by Xinqiao Hospital. Primary endpoint: Incidence of Postpartum Depression at 4 weeks. Started Oct 2017; status: completed.
02
Drugs
tramadol
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on NCT03309163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03309163.